Written and medically reviewed by: Assoc. Prof. Cengiz Dibekoğlu, MD, General SurgeryLast updated:
Breast Disease — Breast Cancer
Subtype (HR/HER2), stage, and nodes shape prognosis conversations with realistic hope.
Breast cancer is many diseases. Hormone receptor and HER2 status, grade, and anatomic stage determine systemic therapy more than the scar length. Early disease is often cured with combined surgery, radiation when indicated, and drugs. Advanced disease still has multiple treatment lines. Inflammatory and triple-negative patterns need especially organized rapid pathways. Triple assessment and subtype biology prevent both under- and over-treatment.
Educational schematic. Some structures may be simplified or emphasized for clarity; not an exact anatomical depiction.
© Cengiz Dibekoğlu — illustrative; not for unauthorized use
Figure summary
This educational figure shows: Cancer.
Who may be a candidate?
- International patients preparing a structured second-opinion visit
- Patients comparing observation, medical care, and procedural options
Possible advantages
- Supports informed consent with alternatives and recovery themes
- Highlights red flags that should trigger urgent contact
Limits & realistic expectations
- Cannot replace examination, imaging, or pathology
- Local protocols and tumor-board decisions may refine timing
- Outcomes vary with anatomy, stage, and comorbidity
Step-by-step overview
- 1
Clarify the clinical question
What diagnosis is being confirmed and what decision follows?
- 2
Choose first-line tests
Start with the test that answers the leading question safely.
- 3
Stage if needed
Add imaging or endoscopy when results would change management.
- 4
Name limitations
No test replaces exam; false reassurance is a risk.
- 5
Link to next step
Diagnosis should point to observation, medical care, or procedure.
Key points
- Key note inside
Important
This page is for education. It is not medical advice and does not replace a visit with your physician.
Frequently asked questions
How is breast cancer confirmed?
Core biopsy with receptor testing, not imaging alone when tissue is obtainable.
Is mastectomy always safer than lumpectomy?
In many early cancers, breast-conserving surgery with radiotherapy is oncologically equivalent when criteria are met.
Why do receptors matter?
ER/PR/HER2 status directs endocrine, anti-HER2, and chemotherapy choices.
Should I discuss genetic testing?
Age and guideline frameworks often support offering germline testing — timing is individualized.
More chapters in this hub
Breast Cysts and Benign Lesions
Simple cysts, fibroadenoma, and when biopsy is discussed
Breast Disease Diagnosis
How clinicians confirm the problem and stage the next steps
Breast Cancer Treatment
How treatment options are matched to risk, stage, and goals
Multidisciplinary Breast Care
Multidisciplinary — explained for shared decision-making
Screening and Follow-Up
Age bands, high-risk MRI, and surveillance after treatment
Appointment / info
This page is for education. It is not medical advice and does not replace a visit with your physician.
Medical editor: Assoc. Prof. Cengiz Dibekoğlu, MD · Last medically reviewed: August 2026 · English patient-education chapter.